Ekso Bionics Files 8-K Amendment
Ticker: EKSO · Form: 8-K/A · Filed: Jul 26, 2024 · CIK: 1549084
| Field | Detail |
|---|---|
| Company | Ekso Bionics Holdings, Inc. (EKSO) |
| Form Type | 8-K/A |
| Filed Date | Jul 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, shareholder-vote
TL;DR
Ekso Bionics filed an amendment to its 8-K on shareholder votes.
AI Summary
Ekso Bionics Holdings, Inc. filed an amendment (No. 1) to its Form 8-K on July 26, 2024, regarding a submission of matters to a vote of security holders. The original report date was June 6, 2024. The company is incorporated in Nevada and its principal executive offices are located in San Rafael, California.
Why It Matters
This filing is an amendment to a previous report concerning matters presented for a shareholder vote, indicating ongoing corporate governance activities.
Risk Assessment
Risk Level: low — This is a procedural amendment to a previous filing and does not introduce new financial or operational risks.
Key Players & Entities
- Ekso Bionics Holdings, Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- San Rafael, California (location) — Principal Executive Offices
- June 6, 2024 (date) — Earliest event reported
- July 26, 2024 (date) — Filing date of amendment
FAQ
What type of filing is this amendment?
This is an amendment (No. 1) to a Form 8-K, specifically concerning the submission of matters to a vote of security holders.
When was the original event reported?
The earliest event reported was on June 6, 2024.
When was this amendment filed?
This amendment was filed on July 26, 2024.
Where is Ekso Bionics Holdings, Inc. incorporated?
Ekso Bionics Holdings, Inc. is incorporated in Nevada.
What is the address of the company's principal executive offices?
The company's principal executive offices are located at 101 Glacier Point, Suite A, San Rafael, California 94901.
Filing Stats: 560 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-07-26 16:15:48
Key Financial Figures
- $0.001 — ge on which registered Common Stock , $0.001 par value per share EKSO Nasdaq Capi
Filing Documents
- ekso20240725_8ka.htm (8-K/A) — 23KB
- 0001437749-24-023606.txt ( ) — 155KB
- ekso-20240606.xsd (EX-101.SCH) — 3KB
- ekso-20240606_def.xml (EX-101.DEF) — 12KB
- ekso-20240606_lab.xml (EX-101.LAB) — 15KB
- ekso-20240606_pre.xml (EX-101.PRE) — 12KB
- ekso20240725_8ka_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On July 25, 2024, the board of directors the Company (the "Board") determined that the Company will hold a stockholder future advisory vote on compensation of the Company's named executive officers annually. This frequency is consistent with the Board's recommendation in the proxy statement relating to Annual Meeting and with the voting results at the Annual Meeting. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EKSO BIONICS HOLDINGS, INC. By: /s/ Jerome Wong Name: Jerome Wong Title: Chief Financial Officer Dated: July 26, 2024